Okayama University is a national university in Japan. The main campus is located in Tsushima-Naka, Okayama, Okayama Prefecture. The school was founded in 1870 and it was established as a university in 1949.

During the past decade, Okayama University conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Okayama University" #1 sponsor was "Okayama University" with 4 trials, followed by "Fresenius Kabi Japan" with 2 trials sponsored, "Baxter Healthcare Corporation" with 1 trials sponsored, "CAVI-J Study Group" with 1 trials sponsored and "Kyoto University, Graduate School of Medicine" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Okayama University" #1 collaborator was "Okayama University" with 2 trials as a collaborator, "Dokkyo Medical University" with 1 trials as a collaborator, "Ehime University Graduate School of Medicine" with 1 trials as a collaborator, "Japanese Gynecologic Oncology Group (JGOG)" with 1 trials as a collaborator and "Ministry of Health, Labour and Welfare, Japan" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Okayama University" are "Activities of Daily Living" (1 trials), "Anesthesia" (1 trials), "BRCA1 and/or BRCA2 Variant Carriers" (1 trials), "Cardiovascular Death" (1 trials) and "Diabetic Neuropathy Peripheral" (1 trials). Many other conditions were trialed in "Okayama University" in a lesser frequency.

Most popular intervention types in "Okayama University" are "Drug" (3 trials), "Other" (2 trials), "Genetic" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "1: Hydroxyethyl starch 130/0.4, 6 %" (1 trials), "6% hydroxyethyl starch 130/0.4" (1 trials), "6% hydroxyethyl starch 70/0.5 (Salinhes®)" (1 trials), "Cardiac progenitor cell infusion" (1 trials) and "Health education for diabetic foot care" (1 trials). Other intervention names were less common.

The vast majority of trials in "Okayama University" are 9 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Okayama University". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Okayama University, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Okayama University, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".

Okayama University has several departments that took part in Clinical trials: "Kawasaki Medical School Hospital; Breast and Thyroid Surgery" - 2 trials, "Department of Dental Anesthesiology and Special Care Dentistry, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences" - 2 trials